NP
BIIB icon

NS Partners’s Biogen BIIB Stock Holding History

NS Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,804
Closed -$2.65M – 111
2018
Q4 		$2.65M Sell
8,804
-75
-0.8% -$23.9K 0.28% 82
2018
Q3 		$3.14M Sell
8,879
-24
-0.3% -$8.26K 0.3% 82
2018
Q2 		$2.58M Hold
8,903
– – 0.27% 84
2018
Q1 		$2.44M Sell
8,903
-291
-3% -$90.3K 0.26% 88
2017
Q4 		$2.93M Buy
9,194
+165
+2% +$52.9K 0.32% 81
2017
Q3 		$2.83M Buy
9,029
+3,086
+52% +$914K 0.34% 81
2017
Q2 		$1.61M Buy
5,943
+368
+7% +$97.3K 0.21% 83
2017
Q1 		$1.52M Sell
5,575
-10,642
-66% -$3.01M 0.22% 89
2016
Q4 		$4.6M Buy
16,217
+111
+0.7% +$32.9K 0.72% 63
2016
Q3 		$5.04M Buy
16,106
+35
+0.2% +$10.4K 0.82% 53
2016
Q2 		$3.89M Buy
16,071
+4,691
+41% +$1.24M 0.66% 66
2016
Q1 		$2.96M Buy
11,380
+235
+2% +$62.1K 0.53% 71
2015
Q4 		$3.41M Sell
11,145
-587
-5% -$169K 0.61% 71
2015
Q3 		$3.42M Sell
11,732
-247
-2% -$81.6K 0.6% 72
2015
Q2 		$4.84M Buy
+11,979
New +$4.81M 0.77% 59

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NS Partners's BIIB Position: Q1 2019 in Review

NS Partners sold out of Biogen (BIIB) in Q1 2019, closing a stake of 8,804 shares — an estimated $2.65M sold.

NS Partners first reported a position in BIIB in Q2 2015 and held it in 15 quarters. The position peaked at $5.04M in Q3 2016. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • NS Partners reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • NS Partners sold 8,804 Biogen shares in Q1 2019, an estimated $2.65M.
  • NS Partners first reported a position in Biogen in Q2 2015 and held it in 15 quarters.
  • NS Partners's Biogen position peaked at $5.04M in Q3 2016.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on NS Partners's 13F filing for Q1 2019, filed 8 May 2019.